当前位置：首页 > 文献互助 > 互助详情

Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency复制

用户6X7Ch8WUQ_gI 1小时前 12 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-03-27 11:32:55 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: https://doi.org/10.1021/acs.jmedchem.5c03107 复制

文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03107复制

其他信息:

出版社: American Chemical Society (ACS)
作者: Qipeng Chai; Maoshuo Yang; Chunxi Liu; Xiaolan Zhu; Lina Liu; Wei Zhao; Xintong Xue; Jinwei Zhang; Lanlan Liu; Wenjing Wang; Fabao Liu; Xiaona You; Yingjie Zhang
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03107

上一篇：Design and Synthesis of Pyrrolo[3,4- d ]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse Model

下一篇：Structure-Based Discovery of a New LpxH-Targeted Chemotype with Activity against Klebsiella pneumoniae

互助时间线

2026-03-20 11:33:54 [完结求助]

楼主确认了书籍探险应助的文件是正确的, 求助状态变成 已完结

2026-03-20 11:32:55 [上传文件]

书籍探险上传了文件(pdf 6.87 MB), 求助状态变成 待确认

2026-03-20 11:32:27 [发起求助]

最新发布的求助

Programming memristor arrays with arbitrarily high precision for analog computing 52分钟前
Receptor activity-modifying protein and small molecule modulation of the gastric inhibitory polypeptide receptor 1小时前
Clinical probability-adjusted (CPA) D-dimer thresholds for the exclusion of venous thromboembolism (VTE) in the emergency department 1小时前
A synthetic humanized camelid single-domain antibody targeting VEGF exhibits in vitro antiangiogenic effects 1小时前
Five things to know about ... D-dimer testing in clinical practice 1小时前
Application of a diagnostic strategy for patients with suspected pulmonary embolism in a middle-income country 1小时前
Structure-Based Discovery of a New LpxH-Targeted Chemotype with Activity against Klebsiella pneumoniae 1小时前
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency 1小时前
Design and Synthesis of Pyrrolo[3,4- d ]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse Model 1小时前
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy 1小时前
Discovery of XYD270 as a Potent, Selective, and Orally Efficacious BRD9 PROTAC for Cancer Therapy 1小时前
Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI Disrupter 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com